Levulinic acid

CAS No. 123-76-2

Levulinic acid( 4-Oxovaleric acid | Laevulinic acid | β-Acetylpropionic acid )

Catalog No. M20243 CAS No. 123-76-2

Levulinic acid derived from the degradation of cellulose is a precursor for the synthesis of biofuels such as ethyl levulinate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 33 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Levulinic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Levulinic acid derived from the degradation of cellulose is a precursor for the synthesis of biofuels such as ethyl levulinate.
  • Description
    Levulinic acid derived from the degradation of cellulose is a precursor for the synthesis of biofuels such as ethyl levulinate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-Oxovaleric acid | Laevulinic acid | β-Acetylpropionic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    Transitional Cell Carcinoma of the Bladder

Chemical Information

  • CAS Number
    123-76-2
  • Formula Weight
    116.12
  • Molecular Formula
    C5H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 100 mg/mL;DMSO: Soluble
  • SMILES
    CC(=O)CCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Z)-PUGNAc

    (Z)-PUGNAc, a potent O-GlcNAcase inhibitor more active than (E)-PUGNAc, removes O-GlcNAc from proteins (peptide O-GlcNAc-β-N-acetylaminoglucosidase) and can be used to increase levels of O-GlcNAc on nuclear and cytoplasmic proteins in vivo.

  • (-)-5-Isopropyl-2-Me...

    (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.

  • Enloplatin

    Enloplatin is a carboplatin analog that has a partial role in advanced ovarian cancer.